Half-year report · Q2
7716.TEDINET S100U5UL
Period2024-01-01 → 2024-06-30
Filed2024-08-09
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 47
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥38.6bn | 2024-01-01 → 2024-06-30 | Cons. | Net sales |
| Revenue | ¥59.7bn | 2023-01-01 → 2023-12-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥28.3bn | 2023-01-01 → 2023-06-30 | Cons. | Net sales |
| Operating income | ¥8.3bn | 2024-01-01 → 2024-06-30 | Cons. | Operating income |
| Operating income | ¥8.0bn | 2023-01-01 → 2023-06-30 | Cons. | Operating income |
| Ordinary income | ¥10.5bn | 2024-01-01 → 2024-06-30 | Cons. | Ordinary income |
| Ordinary income | ¥17.2bn | 2023-01-01 → 2023-12-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥11.0bn | 2023-01-01 → 2023-06-30 | Cons. | Ordinary income |
| Profit before tax | ¥10.5bn | 2024-01-01 → 2024-06-30 | Cons. | Income before income taxes |
| Profit before tax | ¥10.9bn | 2023-01-01 → 2023-06-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥7.0bn | 2024-01-01 → 2024-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥22.8bn | 2023-01-01 → 2023-12-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥8.0bn | 2023-01-01 → 2023-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥7.0bn | 2024-01-01 → 2024-06-30 | Cons. | Profit loss |
| Net income | ¥8.0bn | 2023-01-01 → 2023-06-30 | Cons. | Profit loss |
| Total assets | ¥156.8bn | at 2024-06-30 | Cons. | Assets |
| Total assets | ¥140.8bn | at 2023-12-31 | Cons. | Assets |
| Total assets | ¥111.9bn | at 2023-06-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥32.7bn | at 2024-06-30 | Cons. | Liabilities |
| Total liabilities | ¥27.6bn | at 2023-12-31 | Cons. | Liabilities |
| Net assets / equity | ¥124.0bn | at 2024-06-30 | Cons. | Net assets |
| Net assets / equity | ¥113.2bn | at 2023-12-31 | Cons. | Net assets |
| Net assets / equity | ¥99.3bn | at 2023-06-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥39.3bn | at 2024-06-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥31.7bn | at 2023-12-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥30.1bn | at 2024-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥26.0bn | at 2023-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥35.0bn | at 2023-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥31.6bn | at 2022-12-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥7.3bn | 2024-01-01 → 2024-06-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥8.5bn | 2023-01-01 → 2023-12-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥4.1bn | 2023-01-01 → 2023-06-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥3.9bn | 2024-01-01 → 2024-06-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥19.1bn | 2023-01-01 → 2023-12-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥2.3bn | 2023-01-01 → 2023-06-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥1.4bn | 2024-01-01 → 2024-06-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥3.4bn | 2023-01-01 → 2023-12-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥946m | 2023-01-01 → 2023-06-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥82.88 | 2024-01-01 → 2024-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥267.62 | 2023-01-01 → 2023-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥93.74 | 2023-01-01 → 2023-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥82.63 | 2024-01-01 → 2024-06-30 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥266.87 | 2023-01-01 → 2023-12-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥93.44 | 2023-01-01 → 2023-06-30 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 78.9% | at 2024-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 80.1% | at 2023-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 88.5% | at 2023-06-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 34
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2024-01-01 → 2024-06-30 | −¥126m |
| Reconciling Itemsreconciling | revenue intersegment | 2024-01-01 → 2024-06-30 | −¥126m |
| Reconciling Itemsreconciling | segment profit | 2024-01-01 → 2024-06-30 | −¥2.8bn |
| jpcrp040300-q2r_E02331-000DCI Productsreportable segment | revenue | 2024-01-01 → 2024-06-30 | ¥9.9bn |
| jpcrp040300-q2r_E02331-000DCI Productsreportable segment | revenue external | 2024-01-01 → 2024-06-30 | ¥9.9bn |
| jpcrp040300-q2r_E02331-000DCI Productsreportable segment | segment profit | 2024-01-01 → 2024-06-30 | ¥401m |
| jpcrp040300-q2r_E02331-000Dental Productsreportable segment | revenue | 2024-01-01 → 2024-06-30 | ¥23.5bn |
| jpcrp040300-q2r_E02331-000Dental Productsreportable segment | revenue external | 2024-01-01 → 2024-06-30 | ¥23.3bn |
| jpcrp040300-q2r_E02331-000Dental Productsreportable segment | revenue intersegment | 2024-01-01 → 2024-06-30 | ¥126m |
| jpcrp040300-q2r_E02331-000Dental Productsreportable segment | segment profit | 2024-01-01 → 2024-06-30 | ¥9.2bn |
| jpcrp040300-q2r_E02331-000Industrial Productsreportable segment | revenue | 2024-01-01 → 2024-06-30 | ¥3.3bn |
| jpcrp040300-q2r_E02331-000Industrial Productsreportable segment | revenue external | 2024-01-01 → 2024-06-30 | ¥3.3bn |
| jpcrp040300-q2r_E02331-000Industrial Productsreportable segment | segment profit | 2024-01-01 → 2024-06-30 | ¥415m |
| jpcrp040300-q2r_E02331-000Surgical Productsreportable segment | revenue | 2024-01-01 → 2024-06-30 | ¥2.0bn |
| jpcrp040300-q2r_E02331-000Surgical Productsreportable segment | revenue external | 2024-01-01 → 2024-06-30 | ¥2.0bn |
| jpcrp040300-q2r_E02331-000Surgical Productsreportable segment | segment profit | 2024-01-01 → 2024-06-30 | ¥1.1bn |
| —segment total | revenue | 2024-01-01 → 2024-06-30 | ¥38.7bn |
| —segment total | revenue external | 2024-01-01 → 2024-06-30 | ¥38.6bn |
| —segment total | revenue intersegment | 2024-01-01 → 2024-06-30 | ¥126m |
| —segment total | segment profit | 2024-01-01 → 2024-06-30 | ¥11.1bn |
| Reconciling Itemsreconciling | segment profit | 2023-01-01 → 2023-06-30 | −¥2.6bn |
| jpcrp040300-q2r_E02331-000DCI Productsreportable segment | segment profit | 2023-01-01 → 2023-06-30 | −¥5m |
| jpcrp040300-q2r_E02331-000Dental Productsreportable segment | revenue | 2023-01-01 → 2023-06-30 | ¥22.4bn |
| jpcrp040300-q2r_E02331-000Dental Productsreportable segment | revenue external | 2023-01-01 → 2023-06-30 | ¥22.4bn |
| jpcrp040300-q2r_E02331-000Dental Productsreportable segment | segment profit | 2023-01-01 → 2023-06-30 | ¥9.1bn |
| jpcrp040300-q2r_E02331-000Industrial Productsreportable segment | revenue | 2023-01-01 → 2023-06-30 | ¥4.0bn |
| jpcrp040300-q2r_E02331-000Industrial Productsreportable segment | revenue external | 2023-01-01 → 2023-06-30 | ¥4.0bn |
| jpcrp040300-q2r_E02331-000Industrial Productsreportable segment | segment profit | 2023-01-01 → 2023-06-30 | ¥670m |
| jpcrp040300-q2r_E02331-000Surgical Productsreportable segment | revenue | 2023-01-01 → 2023-06-30 | ¥1.8bn |
| jpcrp040300-q2r_E02331-000Surgical Productsreportable segment | revenue external | 2023-01-01 → 2023-06-30 | ¥1.8bn |
| jpcrp040300-q2r_E02331-000Surgical Productsreportable segment | segment profit | 2023-01-01 → 2023-06-30 | ¥889m |
| —segment total | revenue | 2023-01-01 → 2023-06-30 | ¥28.3bn |
| —segment total | revenue external | 2023-01-01 → 2023-06-30 | ¥28.3bn |
| —segment total | segment profit | 2023-01-01 → 2023-06-30 | ¥10.6bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 554
| Item | Context | Value | Unit |
|---|---|---|---|
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q2r_E02331-000IndustrialProductsReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_ReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_ReconcilingItemsMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration | － | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q2r_E02331-000DentalProductsReportableSegmentsMember | 22448932000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q2r_E02331-000DCIProductsReportableSegmentsMember | － | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q2r_E02331-000SurgicalProductsReportableSegmentsMember | 1779394000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q2r_E02331-000IndustrialProductsReportableSegmentsMember | 4031098000 | JPY |
| Net sales | Prior1YTDDuration_ReportableSegmentsMember | 28259425000 | JPY |
| Net sales | Prior1YTDDuration_ReconcilingItemsMember | － | JPY |
| Net sales | Prior1YTDDuration | 28259425000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q2r_E02331-000DentalProductsReportableSegmentsMember | 9057119000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q2r_E02331-000DCIProductsReportableSegmentsMember | -5448000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q2r_E02331-000SurgicalProductsReportableSegmentsMember | 888937000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q2r_E02331-000IndustrialProductsReportableSegmentsMember | 670379000 | JPY |
| Operating income | Prior1YTDDuration_ReportableSegmentsMember | 10610988000 | JPY |
| Operating income | Prior1YTDDuration_ReconcilingItemsMember | -2572124000 | JPY |
| Operating income | Prior1YTDDuration | 8038863000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q2r_E02331-000DentalProductsReportableSegmentsMember | 23335326000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q2r_E02331-000DCIProductsReportableSegmentsMember | 9933219000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q2r_E02331-000SurgicalProductsReportableSegmentsMember | 2022635000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q2r_E02331-000IndustrialProductsReportableSegmentsMember | 3266062000 | JPY |
| Revenues from external customers | CurrentYTDDuration_ReportableSegmentsMember | 38557243000 | JPY |
| Revenues from external customers | CurrentYTDDuration_ReconcilingItemsMember | － | JPY |
| Revenues from external customers | CurrentYTDDuration | 38557243000 | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q2r_E02331-000DentalProductsReportableSegmentsMember | 126286000 | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q2r_E02331-000DCIProductsReportableSegmentsMember | － | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q2r_E02331-000SurgicalProductsReportableSegmentsMember | － | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q2r_E02331-000IndustrialProductsReportableSegmentsMember | － | JPY |
| Transactions with other segments | CurrentYTDDuration_ReportableSegmentsMember | 126286000 | JPY |
| Transactions with other segments | CurrentYTDDuration_ReconcilingItemsMember | -126286000 | JPY |
| Transactions with other segments | CurrentYTDDuration | － | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q2r_E02331-000DentalProductsReportableSegmentsMember | 23461613000 | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q2r_E02331-000DCIProductsReportableSegmentsMember | 9933219000 | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q2r_E02331-000SurgicalProductsReportableSegmentsMember | 2022635000 | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q2r_E02331-000IndustrialProductsReportableSegmentsMember | 3266062000 | JPY |
| Net sales | CurrentYTDDuration_ReportableSegmentsMember | 38683530000 | JPY |
| Net sales | CurrentYTDDuration_ReconcilingItemsMember | -126286000 | JPY |
| Net sales | CurrentYTDDuration | 38557243000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q2r_E02331-000DentalProductsReportableSegmentsMember | 9235018000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q2r_E02331-000DCIProductsReportableSegmentsMember | 400517000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q2r_E02331-000SurgicalProductsReportableSegmentsMember | 1051914000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q2r_E02331-000IndustrialProductsReportableSegmentsMember | 415122000 | JPY |
| Operating income | CurrentYTDDuration_ReportableSegmentsMember | 11102573000 | JPY |
| Operating income | CurrentYTDDuration_ReconcilingItemsMember | -2815394000 | JPY |
| Operating income | CurrentYTDDuration | 8287179000 | JPY |
| Document title cover page | FilingDateInstant | Original text (Japanese)半期報告書 | |
| Clause of stipulation cover page | FilingDateInstant | Original text (Japanese)金融商品取引法第24条の５第１項の表の第１号 | |
| Place of filing cover page | FilingDateInstant | Original text (Japanese)関東財務局長 | |
| Filing date cover page | FilingDateInstant | 2024-08-09 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |